US44148G2049 - HOTH (XNAS)
Hoth Therapeutics, Inc. - Common Stock Action
0,79 USD
Cours actuels de Hoth Therapeutics, Inc. - Common Stock
Bourse | Ticker | Devise | Dernier échange | Cours | Variation journalière | Variation journalière % |
---|---|---|---|---|---|---|
NASDAQ |
HOTH
|
USD
|
27.12.2024 01:59
|
0,79 USD
| 0,76 USD | 3,82 % |
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
1,28 % | -3,78 % | -3,55 % | -10,34 % | -12,19 % | -41,56 % | -99,39 % |
Company Profile for Hoth Therapeutics, Inc. - Common Stock Share
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-ALZ for the treatment and/or prevention of Alzheimer's or other neuroinflammatory diseases; HT-003 to treat inflammatory bowel diseases, as well as acne and psoriasis; HT-004 for treatment of asthma and allergies using inhalational administration; HT-006 to treat lung diseases resulting from bacterial infections; and HT-002, a novel peptide for treating COVID-19. The company is also developing BioLexa Platform, a proprietary, patented, drug compound platform which is in phase I clinical trial for the treatment of eczema; and HT-005 for treating patients with lupus. The company has license agreements with the George Washington University; the University of Maryland; Isoprene Pharmaceuticals, Inc.; the North Carolina State University; Chelexa BioSciences, Inc.; Zylö Therapeutics, Inc., and the University of Cincinnati. It also has a research collaboration agreement with Weill Cornell Medicine to develop HT-003. Hoth Therapeutics, Inc. was incorporated in 2017 and is headquartered in New York, New York.
Company Data for Hoth Therapeutics, Inc. - Common Stock Share
Name Hoth Therapeutics, Inc. - Common Stock
Company Hoth Therapeutics, Inc.
Symbol HOTH
Website https://www.hoththerapeutics.com
Primary Exchange
NASDAQ
ISIN US44148G2049
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Robb Knie
Country United States of America
Currency USD
Employees 0,0 T
Address 1 Rockefeller Plaza, 10020 New York
IPO Date 2019-02-15
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | HOTH |
More Shares
Investors who Hoth Therapeutics, Inc. - Common Stock hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.